androstane-3,17-diol has been researched along with Alopecia in 8 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (25.00) | 18.7374 |
1990's | 5 (62.50) | 18.2507 |
2000's | 1 (12.50) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Caballero, MJ | 1 |
Mallol, J; Puerto, AM | 1 |
Carrington, P; Cole, GW; Cotterill, PC; Dallob, A; Drake, L; Epstein, ES; Fiedler, V; Geissler, L; Gencheff, C; Griffin, EI; Hordinsky, M; Jacobson, C; Kraus, SJ; Lowe, N; Pariser, DM; Stieglitz, S; Swinehart, J; Tanaka, W; Thiboutot, DM; Unger, WP; Vandormael, K; Waldstreicher, J; Weiss, D; Whiting, D | 1 |
Abramovici, Y; Boudou, P; Chaspoux, C; Fiet, J; Hardy, N; Reygagne, P; Rueda, MJ; Vexiau, P | 1 |
Dericks-Tan, JS; Kuhl, H; Taubert, HD; Vogt, C | 1 |
Callan, A; Connelly, JF; Davies, HE; Funder, JW; Montalto, J; Whorwood, CB; Yong, AB | 1 |
De Villez, RL; Dunn, J | 1 |
Loriaux, DL; Mellin, TN; Povar, ML; Rittmaster, RS; Uno, H | 1 |
1 trial(s) available for androstane-3,17-diol and Alopecia
Article | Year |
---|---|
The effects of finasteride on scalp skin and serum androgen levels in men with androgenetic alopecia.
Topics: 5-alpha Reductase Inhibitors; Adolescent; Adult; Alopecia; Androgens; Androstane-3,17-diol; Dihydrotestosterone; Double-Blind Method; Enzyme Inhibitors; Finasteride; Humans; Male; Middle Aged; Scalp; Testosterone | 1999 |
7 other study(ies) available for androstane-3,17-diol and Alopecia
Article | Year |
---|---|
Metabolism of 5 alpha-androstane-3 beta,17 beta-diol in bald and hairy areas of the scalp.
Topics: Alopecia; Androstane-3,17-diol; Androsterone; Dihydrotestosterone; Etiocholanolone; Gas Chromatography-Mass Spectrometry; Humans; Kinetics; Male; Scalp | 1994 |
Guanylate cyclase activity in male pattern baldness. Stimulating effect of 3-beta-androstanediol.
Topics: Alopecia; Androstane-3,17-diol; Cyclic AMP; Cyclic GMP; Cytosol; Dihydrotestosterone; Guanylate Cyclase; Humans; Hypertrophy; Kinetics; Male; Scalp; Sebaceous Glands; Second Messenger Systems; Stimulation, Chemical | 1993 |
Role of androgens in female-pattern androgenetic alopecia, either alone or associated with other symptoms of hyperandrogenism.
Topics: Adolescent; Adult; Age of Onset; Alopecia; Androgens; Androstane-3,17-diol; Case-Control Studies; Female; Humans; Hyperandrogenism; Middle Aged; Severity of Illness Index; Sex Hormone-Binding Globulin | 2000 |
Is 3 alpha, 17 beta-androstanediol-glucuronide a diagnostic marker in women with androgenic manifestations?
Topics: Acne Vulgaris; Adolescent; Adult; Alopecia; Androgens; Androstane-3,17-diol; Biomarkers; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Female; Hirsutism; Humans; Middle Aged; Oligomenorrhea; Testosterone | 1992 |
Plasma C19 steroid sulphate levels and indices of androgen bioavailability in female pattern androgenic alopecia.
Topics: Adolescent; Adult; Alopecia; Androgens; Androstane-3,17-diol; Androstenediol; Androstenedione; Biological Availability; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Female; Follicle Stimulating Hormone; Humans; Luteinizing Hormone; Middle Aged; Radioimmunoassay; Sex Hormone-Binding Globulin; Testosterone | 1990 |
Female androgenic alopecia. The 3 alpha,17 beta-androstanediol glucuronide/sex hormone binding globulin ratio as a possible marker for female pattern baldness.
Topics: Adult; Alopecia; Androgens; Androstane-3,17-diol; Androstanols; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Dihydrotestosterone; Female; Humans; Middle Aged; Sex Hormone-Binding Globulin; Testosterone | 1986 |
The effects of N,N-diethyl-4-methyl-3-oxo-4-aza-5 alpha-androstane-17 beta-carboxamide, a 5 alpha-reductase inhibitor and antiandrogen, on the development of baldness in the stumptail macaque.
Topics: Alopecia; Androgen Antagonists; Androstane-3,17-diol; Animals; Azasteroids; Cholestenone 5 alpha-Reductase; Dihydrotestosterone; Disease Models, Animal; Female; Hair; Macaca; Male; Oxidoreductases; Skin; Steroids, Heterocyclic; Testosterone | 1987 |